AQST vs HUBB · rev $28.3M vs P/E 28, rev $5.84B
Aquestive Therapeutics Inc (AQST) versus Hubbell Inc (HUBB) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported HUBB revenue for 2025-12-31 was $5.84B. Net income was $887.1M. Revenue was up 3.8% from 2024-12-31 to 2025-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
AQST currently screens at market cap $493.0M. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
Not investment advice. Open the AQST and HUBB stock pages for the full models.
Not investment advice.